Logo image of LION

LIONSGATE STUDIOS CORP (LION) Stock Fundamental Analysis

USA - NYSE:LION - CA53626N1024 - Common Stock

6.5 USD
-0.01 (-0.15%)
Last: 10/3/2025, 8:04:00 PM
6.62 USD
+0.12 (+1.85%)
After Hours: 10/3/2025, 8:04:00 PM
Fundamental Rating

1

Overall LION gets a fundamental rating of 1 out of 10. We evaluated LION against 80 industry peers in the Entertainment industry. LION may be in some trouble as it scores bad on both profitability and health. LION has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

LION had negative earnings in the past year.
LION had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: LION reported negative net income in multiple years.
LION had a negative operating cash flow in each of the past 5 years.
LION Yearly Net Income VS EBIT VS OCF VS FCFLION Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

LION has a Return On Assets (-2.70%) which is comparable to the rest of the industry.
LION has a better Return On Invested Capital (4.15%) than 72.50% of its industry peers.
Industry RankSector Rank
ROA -2.7%
ROE N/A
ROIC 4.15%
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LION Yearly ROA, ROE, ROICLION Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

LION's Operating Margin of 5.41% is fine compared to the rest of the industry. LION outperforms 67.50% of its industry peers.
With an excellent Gross Margin value of 117.71%, LION belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
OM 5.41%
PM (TTM) N/A
GM 117.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LION Yearly Profit, Operating, Gross MarginsLION Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

0

2. Health

2.1 Basic Checks

There is no outstanding debt for LION. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LION Yearly Shares OutstandingLION Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
LION Yearly Total Debt VS Total AssetsLION Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.19, we must say that LION is in the distress zone and has some risk of bankruptcy.
LION has a Altman-Z score of -0.19. This is in the lower half of the industry: LION underperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.19
ROIC/WACCN/A
WACCN/A
LION Yearly LT Debt VS Equity VS FCFLION Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

LION has a Current Ratio of 0.36. This is a bad value and indicates that LION is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.36, LION is doing worse than 86.25% of the companies in the same industry.
A Quick Ratio of 0.36 indicates that LION may have some problems paying its short term obligations.
The Quick ratio of LION (0.36) is worse than 85.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
LION Yearly Current Assets VS Current LiabilitesLION Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

2

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.62%

3.2 Future

LION is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.79% yearly.
Based on estimates for the next years, LION will show a small growth in Revenue. The Revenue will grow by 1.83% on average per year.
EPS Next Y-220.55%
EPS Next 2Y71.99%
EPS Next 3Y60.79%
EPS Next 5YN/A
Revenue Next Year-14.41%
Revenue Next 2Y1.79%
Revenue Next 3Y1.83%
Revenue Next 5YN/A

3.3 Evolution

LION Yearly Revenue VS EstimatesLION Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 1B 2B 3B
LION Yearly EPS VS EstimatesLION Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 0.1 -0.1 0.2 0.3 0.4

3

4. Valuation

4.1 Price/Earnings Ratio

LION reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
LION is valuated rather expensively with a Price/Forward Earnings ratio of 19.98.
Based on the Price/Forward Earnings ratio, LION is valued cheaper than 85.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, LION is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 19.98
LION Price Earnings VS Forward Price EarningsLION Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LION is valued cheaper than 93.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.76
LION Per share dataLION EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

LION's earnings are expected to grow with 60.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.99%
EPS Next 3Y60.79%

0

5. Dividend

5.1 Amount

No dividends for LION!.
Industry RankSector Rank
Dividend Yield N/A

LIONSGATE STUDIOS CORP

NYSE:LION (10/3/2025, 8:04:00 PM)

After market: 6.62 +0.12 (+1.85%)

6.5

-0.01 (-0.15%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05
Inst Owners69.3%
Inst Owner Change783.53%
Ins Owners3.69%
Ins Owner Change-1802.63%
Market Cap1.88B
Analysts80
Price Target8.78 (35.08%)
Short Float %4.61%
Short Ratio4.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)303.17%
Min EPS beat(2)-20.6%
Max EPS beat(2)626.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.83%
Min Revenue beat(2)0.44%
Max Revenue beat(2)3.22%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.88%
PT rev (3m)-4.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.98
P/S 0.89
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 3.76
EPS(TTM)-0.2
EYN/A
EPS(NY)0.33
Fwd EY5.01%
FCF(TTM)-1.28
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS7.34
BVpS-3.73
TBVpS-15.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.7%
ROE N/A
ROCE 5.25%
ROIC 4.15%
ROICexc 4.53%
ROICexgc N/A
OM 5.41%
PM (TTM) N/A
GM 117.71%
FCFM N/A
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 1.48
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z -0.19
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)0.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3100%
EPS Next Y-220.55%
EPS Next 2Y71.99%
EPS Next 3Y60.79%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.62%
Revenue Next Year-14.41%
Revenue Next 2Y1.79%
Revenue Next 3Y1.83%
Revenue Next 5YN/A
EBIT growth 1Y331.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1414.8%
EBIT Next 3Y153.73%
EBIT Next 5Y101.33%
FCF growth 1Y-72843.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70899.5%
OCF growth 3YN/A
OCF growth 5YN/A